Emodin, a natural product, selectively inhibits 11β‐hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet‐induced obese mice

@article{Feng2010EmodinAN,
  title={Emodin, a natural product, selectively inhibits 11β‐hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet‐induced obese mice},
  author={Y. Feng and Su-Ling Huang and W. Dou and Song Zhang and Jun-hua Chen and Y. Shen and J. Shen and Y. Leng},
  journal={British Journal of Pharmacology},
  year={2010},
  volume={161}
}
  • Y. Feng, Su-Ling Huang, +5 authors Y. Leng
  • Published 2010
  • Biology, Medicine
  • British Journal of Pharmacology
    • BACKGROUND AND PURPOSE 11β‐Hydroxysteroid dehydrogenase type 1 (11β‐HSD1) is an attractive therapeutic target of type 2 diabetes and metabolic syndrome. Emodin, a natural product and active ingredient of various Chinese herbs, has been demonstrated to possess multiple biological activities. Here, we investigated the effects of emodin on 11β‐HSD1 and its ability to ameliorate metabolic disorders in diet‐induced obese (DIO) mice. 
    View on Wiley
    bpspubs.onlinelibrary.wiley.com
    97 Citations
    Highly Influential Citations
    4
    Background Citations
    39
    Methods Citations
    4
    97 Citations
    Citation Type

    Citation Type

    Inhibition of 11β‐hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice
    • 17
    11β-Hydroxysteroid dehydrogenase type 1, a target for development of oral antidiabetic drugs (Review)
    • 1
    Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice
    • 23
    • PDF
    11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome.
    • 24
    • PDF
    11β-hydroxysteroid dehydrogenase type 1 inhibitor use in human disease- a systematic review and narrative synthesis.
    • 1
    Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice.
    • 6
    • PDF
    Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
    • 17
    • Highly Influenced
    Inhibition of 11 b-HSD 1 by LG 13 improves glucose metabolism in type 2 diabetic mice
    • PDF
    Mechanisms of Action of Phenolic Phytochemicals in Diabetes Management
    • 2
    Endocrine disruptors and other inhibitors of 11β-hydroxysteroid dehydrogenase 1 and 2: Tissue-specific consequences of enzyme inhibition
    • 22

    References

    SHOWING 1-10 OF 63 REFERENCES
    Increased expression of 11β‐hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes
    • 76
    11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
    • 377
    • PDF
    Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    • 93
    • PDF
    Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
    • N. Morton
    • Biology, Medicine
    • Molecular and Cellular Endocrinology
    • 2010
    • 155
    • PDF
    Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    • 74
    • PDF
    Effects of the 11β-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes
    • 238
    • PDF
    Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluation.
    • 36
    Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
    • 260
    • PDF
    Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
    • 57
    Anti‐cancer properties of anthraquinones from rhubarb
    • 398